BioSpace News Archive

Syros Pharmaceuticals, a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, highlighted anticipated 2024 milestones to deliver on the value of tamibarotene.

Alentis Therapeutics announced that Dr. William Pao will join its Board of Directors as an independent member effective immediately.

ICON plc, a world-leading healthcare intelligence and clinical research organisation, launched its “Optimising biotech funding” whitepaper.

Novocure reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2023.

Tryp Therapeutics, Inc. (“Tryp” or the “Company”) (CSE:TRYP)(OTCQB:TRYPF), a pioneering clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs,today announced a significant milestone in its clinical trial program for TRP-8803 (IV-infused psilocin).

SpringWorks Therapeutics, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference at 7:30 a.m. PT, and a live webcast will be available at ir.springworkstx.com.

Ironwood Pharmaceuticals, Inc., a GI-focused healthcare company, announced financial guidance for full year 2024.

Flagship Pioneering, the bioplatform innovation company, and Samsung announced a collaboration aimed at fostering cutting-edge biopharmaceutical innovation poised to transform the world of healthcare through groundbreaking advancements in translational science and medicine.

Sage Therapeutics, Inc., a biopharmaceutical company leading the way to create a world with better brain health, announced the retirement of Kevin Starr from the company’s board of directors.

Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and patient, provided a preliminary 2023 year-end corporate update.